Clinical Trial Update: PDC-1421 Treatment in Adult Patients With ADHD [Phase 2]

View source ↗

Summary

Phase 2 trial of PDC-1421 in adults with attention-deficit/hyperactivity disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• PDC-1421

Snippet

Sponsor: BioLite, Inc. | Conditions: Attention-Deficit Hyperactivity Disorder (ADHD) | Phase 2 | Status: COMPLETED